TTop stories Read More FDA clears Replimune melanoma drug RP1 for continued testingAugust 7, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
TTop stories Read More AstraZeneca and Bristol Myers Squibb mull $400 billion deal: ReportAugust 2, 2026 A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…
TTop stories Read More Cyclospora: CDC says outbreak is in nine statesJuly 24, 2026 A customer shops for cilantro at a Walmart Supercenter on July 23, 2026, in Austin, Texas. Brandon Bell…
TTop stories Read More Eli Lilly will file for approval of retatrutide obesity drug in 2027July 23, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
TTop stories Read More Trump’s generic drug tariffs: What it means for patients, drugmakers and pricesJuly 22, 2026 President Donald Trump‘s proposed tariffs on imported generic medicines have raised fresh questions about whether low-cost drugmakers can…
BBreaking News Read More What Europe’s debate about Israel often misses: The human cost of warJuly 21, 2026 Last week, I spent part of a morning visiting four pharmacies to collect my father’s regular medications. It…
TTop stories Read More What to know about testosterone replacement therapyJuly 20, 2026 US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on…
TTop stories Read More UnitedHealth Group (UNH) earnings Q2 2026July 16, 2026 UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as…
TTop stories Read More U.S. appeals court revives private lawsuits linking Tylenol to autismJuly 13, 2026 Tylenol is displayed for sale at a CVS Pharmacy on Nov. 3, 2025 in Austin, Texas. Brandon Bell…
TTop stories Read More AstraZeneca, Ionis report major trial failure with heart disease drugJuly 9, 2026 Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
TTop stories Read More FDA approves Vera Therapeutics kidney disease treatmentJuly 7, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Anthropic, AI powerhouse, announces it will begin developing drugs of its ownJuly 1, 2026 Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…